Literature DB >> 11757335

Compact, reliable ventricular assist device as a bridge to recovery or for semipermanent use.

K Nishimura1, S Kono, T Nishina, K Ueyama, A Ikai, T Ikeda, C Nojiri, T Akamatsu, M Komeda.   

Abstract

OBJECTIVES: The magnetically suspended centrifugal pump has gained attention as an implantable ventricular assist device for long-term use. We report recovery-oriented pump operation and results of a chronic animal experiment.
METHODS: In an acute experiment in 8 sheep having microspheres injected to induce heart failure, left ventricular assist was implemented by 2 inflow cannulas, 1 each in the left atrium and left ventricle. The pressure-volume loop of the left ventricle and myocardial oxygen consumption were measured varying the assist rate. The chronic animal experiment used 10 sheep whose native heart was kept intact. Continuous hemodynamic monitoring and periodic blood sampling were conducted.
RESULTS: In the acute study, myocardial oxygen consumption decreased proportionally with increasing assist rate in left atrial drainage, but was significantly less at a 100% assist rate in left ventricular drainage. External work in left ventricular drainage did not decrease until a 75% assist rate, suggesting that the left ventricle shape and size were maintained despite decreased myocardial oxygen consumption. In the chronic experiment, the pumping duration was 14 to 248 days. No thrombi or emboli in the pump or any major organ were found in sacrificed sheep after living more than 100 days. Hepatic and renal function were within an almost normal range throughout the experiment.
CONCLUSION: Left ventricular blood drainage effectively reduced oxygen consumption, maintaining the shape of the left ventricle. The magnetically suspended centrifugal pump is suitable for recovery of a failing heart or semipermanent use.

Entities:  

Mesh:

Year:  2001        PMID: 11757335     DOI: 10.1007/bf02912472

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  21 in total

1.  Recovery of cardiac function by long-term left ventricular support in patients with end-stage cardiomyopathy.

Authors:  T Nakatani; Y Sasako; J Kobayashi; K Komamura; Y Kosakai; K Nakano; F Yamamoto; K Kumon; K Miyatake; S Kitamura; H Takano
Journal:  ASAIO J       Date:  1998 Sep-Oct       Impact factor: 2.872

2.  In vivo testing of a magnetically suspended centrifugal pump designed for long-term use.

Authors:  T Yamada; K Nishimura; T Akamatsu; T Tsukiya; C H Park; S Kono; K Matsuda; T Ban
Journal:  Int J Artif Organs       Date:  1997-10       Impact factor: 1.595

3.  Effect of cannulation site on the primary determinants of myocardial oxygen consumption during left heart bypass.

Authors:  D J Cohen; D C Kress; D K Swanson; L W DeBoer; H A Berkoff
Journal:  J Surg Res       Date:  1989-08       Impact factor: 2.192

4.  Long-term in vivo left ventricular assist device study for 284 days with Gyro PI pump.

Authors:  G Ohtsuka; K Nakata; M Yoshikawa; T Takano; J Glueck; Y Sankai; Y Takami; J Mueller; A Sueoka; G Letsou; H Schima; H Schmallegger; E Wolner; H Koyanagi; A Fujisawa; J C Baldwin; Y Nosé
Journal:  Artif Organs       Date:  1999-06       Impact factor: 3.094

5.  Reduction of myocardial infarct volume: comparison between left atrial and left ventricular bypass.

Authors:  J L Pennock; W E Pae; G A Prophet; W S Pierce; J A Waldhausen
Journal:  Surg Forum       Date:  1977

6.  Clinical effects of ventricular assist system in end-stage cardiac failure. Advantages of left ventricular blood drainage for recovery from cardiac dysfunction.

Authors:  S Kyo; H Tanabe; H Asano; H Ohuchi; H Nogaki; M Ishikawa; Y Yokote; T Koyanagi; H Noda; R Omoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-07

7.  An implantable centrifugal blood pump for long term circulatory support.

Authors:  K Yamazaki; P Litwak; R L Kormos; T Mori; O Tagusari; J F Antaki; M Kameneva; M Watach; L Gordon; M Umezu; J Tomioka; H Koyanagi; B P Griffith
Journal:  ASAIO J       Date:  1997 Sep-Oct       Impact factor: 2.872

8.  Improved left ventricular function after chronic left ventricular unloading.

Authors:  O H Frazier; C R Benedict; B Radovancevic; R J Bick; P Capek; W E Springer; M P Macris; R Delgado; L M Buja
Journal:  Ann Thorac Surg       Date:  1996-09       Impact factor: 4.330

9.  Left atrial or ventricular cannulation beyond 30 days for a Thoratec ventricular assist device.

Authors:  W L Holman; R C Bourge; C P Murrah; D C McGiffin; R D Spruell; E R Ferguson; J K Kirklin
Journal:  ASAIO J       Date:  1995 Jul-Sep       Impact factor: 2.872

10.  Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure.

Authors:  K Dipla; J A Mattiello; V Jeevanandam; S R Houser; K B Margulies
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.